Multimodal Recurrence Scoring System for Stratifying Stage III Clear Cell Renal Cell Carcinoma of Receiving Adjuvant Treatment
Condition: Renal Cell Carcinoma Intervention: Drug: Sunitinib Sponsor: First Affiliated Hospital, Sun Yat-Sen University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Hospitals | Kidney Cancer | Renal Cell Carcinoma | Research